Alkynylpurine compounds and production methods thereof
Abstract
The present invention relates to alkynylpurine compounds represented by the following formula (I-1) and the formula (I-2): wherein each symbol is as defined in the present specification, salts thereof, and production methods thereof. According to the present invention, a method of producing an alkynylpurine compound and a salt thereof useful as an intermediate for medicament production safely, conveniently and economically from the corresponding purine compound and a salt thereof, as well as an alkynylpurine compound and a salt thereof useful as an intermediate for production of medicaments can be provided.
Claims
exact text as granted — not AI-modified1 . A compound represented by the formula (I-1):
wherein
X 1 is an alkyl group, an alkoxy group, an aryl group, an optionally protected amino group, a halogen atom or a hydrogen atom,
one of Y 1
is a group represented by the formula: R—C≡C—
wherein R is a hydrogen atom, a hydrocarbon group optionally having substituents, an aryl group optionally having substituents or a heterocyclic group optionally having substituents, and the other
Y 1 is a hydrogen atom, and
Z 1 is an alkyl group, a sugar group, an amino-protecting group or a hydrogen atom, which is attached to a nitrogen atom at the 7- or 9-position of the purine nucleus,
or a salt thereof.
2 . The compound of claim 1 , wherein X 1 is a halogen atom, R is a hydrogen atom or Me 2 (OH)C—, and Z 1 is an amino-protecting group or a hydrogen atom.
3 . The compound of claim 1 , wherein X 1 is a chlorine atom.
4 . The compound of any of claim 1 , wherein Z 1 is tetrahydropyran-2-yl, benzyl or a hydrogen atom.
5 . A compound represented by the formula (1-2):
wherein
R is a hydrogen atom, a hydrocarbon group optionally having substituents, an aryl group optionally having substituents or a heterocyclic group optionally having substituents,
X 2 is an alkyl group, an alkoxy group, an aryl group, an optionally protected amino group, a halogen atom or a hydrogen atom, and
Z 2 is an alkyl group, a sugar group, an amino-protecting group or a hydrogen atom, which is attached to a nitrogen atom at the 7- or 9-position of the purine nucleus,
or a salt thereof.
6 . The compound of claim 5 , wherein R is a hydrogen atom or Me 2 (OH)C—, X 2 is an optionally protected amino group, and Z 2 is an amino-protecting group or a hydrogen atom.
7 . The compound of claim 5 , wherein Z 2 is tetrahydropyran-2-yl, benzyl or a hydrogen atom.
8 . A production method of a compound represented by the formula (I-I′):
wherein
X 1 is an alkyl group, an alkoxy group, an aryl group, an optionally protected amino group, a halogen atom or a hydrogen atom,
Z 1 is an alkyl group, a sugar group, an amino-protecting group or a hydrogen atom, which is attached to a nitrogen atom at the 7- or 9-position of the purine nucleus, and
one of Y 1′ is a group represented by the formula: Me 2 (OH)C—C≡C—, and the other Y 1′ is a hydrogen atom,
or a salt thereof, which comprises reacting a compound represented by the formula (II-1):
wherein
X 1 and Z 1 are as defined above, and
one of L 1 is a halogen atom, and the other L 1 is a hydrogen atom, provided that when X 1 is a halogen atom, L 1 is a halogen atom having higher leaving ability than the halogen atom represented by X 1 ,
or a salt thereof, with a compound represented by the formula (III): Me 2 (OH)C—C≡CH, in the presence of a metal catalyst and a base (1).
9 . A production method of a compound represented by the formula (I-1″):
wherein
X 1 is an alkyl group, an alkoxy group, an aryl group, an optionally protected amino group, a halogen atom or a hydrogen atom,
Z 1 is an alkyl group, a sugar group, an amino-protecting group or a hydrogen atom, which is attached to a nitrogen atom at the 7- or 9-position of the purine nucleus, and
one of Y 1″ is a group represented by the formula: HC≡C—, and the other Y 1″ is a hydrogen atom,
or a salt thereof, which comprises treating a compound represented by the formula (I- I′):
wherein
X 1 and Z 1 are as defined above, and
one of Y 1′ is a group represented by the formula: Me 2 (OH)C—C≡C—, and the other Y 1′ is a hydrogen atom,
or a salt thereof, with a base (2).
10 . A production method of a compound represented by the formula (I-1′″):
wherein
X 1 is an alkyl group, an alkoxy group, an aryl group, an optionally protected amino group, a halogen atom or a hydrogen atom,
Z 1 is an alkyl group, a sugar group, an amino-protecting group or a hydrogen atom, which is attached to a nitrogen atom at the 7- or 9-position of the purine nucleus, and
one of Y 1′″ is a group represented by the formula: A-C≡C—, wherein A is an aryl group optionally having substituents or a heterocyclic group optionally having substituents, and the other Y 1′″ is a hydrogen atom,
or a salt thereof, which comprises reacting a compound represented by the formula (I-1″):
wherein
X 1 and Z 1 are as defined above, and
one of Y 1″ is a group represented by the formula: HC≡C—, and the other Y 1″ is a hydrogen atom,
or a salt thereof, with a compound represented by the formula (IV): A-X wherein A is as defined above, and X is a halogen atom, in the presence of a metal catalyst and a base (1).
11 . A production method of a compound represented by the formula (I-1′″):
wherein
X 1 is an alkyl group, an alkoxy group, an aryl group, an optionally protected amino group, a halogen atom or a hydrogen atom,
one of Y 1′″ is a group represented by the formula: A-C≡C—, wherein A is an aryl group optionally having substituents or a heterocyclic group optionally having substituents, and the other Y 1′″ is a hydrogen atom, and
Z 1 is an alkyl group, a sugar group, an amino-protecting group or a hydrogen atom, which is attached to a nitrogen atom at the 7- or 9-position of the purine nucleus,
or a salt thereof, which comprises the following steps (a)-(c):
(a) a step of obtaining a compound represented by the formula (I-1′):
wherein
X 1 is an alkyl group, an alkoxy group, an aryl group, an optionally protected amino group, a halogen atom or a hydrogen atom,
Z 1 is an alkyl group, a sugar group, an amino-protecting group or a hydrogen atom, which is attached to a nitrogen atom at the 7- or 9-position of the purine nucleus, and
one of Y 1′ is a group represented by the formula: Me 2 (OH)C—C≡C—, and the other Y 1′ is a hydrogen atom,
or a salt thereof, which comprises reacting a compound represented by the formula (II-1):
wherein
X 1 and Z 1 are as defined above, and
one of L 1 is a halogen atom, and the other L 1 is a hydrogen atom, provided that when X 1 is a halogen atom, L 1 is a halogen atom having higher leaving ability than the halogen atom represented by X 1 ,
or a salt thereof, with a compound represented by the formula (III): Me 2 (OH)C—C≡CH, in the presence of a metal catalyst and a base (1),
(b) a step of obtaining a compound represented by the formula (I-1″):
wherein
X 1 and Z 1 are as defined above, and
one of Y 1″ is a group represented by the formula: HC≡C—, and the other Y 1″ is a hydrogen atom, or a salt thereof, which comprises treating a compound of the formula (I-1′) obtained in the step (a) or a salt thereof with a base (2), and
(c) a step of reacting a compound of the formula (I-1″) obtained in the step (b) or a salt thereof, with a compound represented by the formula (IV): A-X wherein A is an aryl group optionally having substituents or a heterocyclic group optionally having substituents, and X is a halogen atom, in the presence of a metal catalyst and a base (1).
12 . A production method of a compound represented by the formula (I-2′):
wherein
X 2 is an alkyl group, an alkoxy group, an aryl group, an optionally protected amino group, a halogen atom or a hydrogen atom, and
Z 2 is an alkyl group, a sugar group, an amino-protecting group or a hydrogen atom, which is attached to a nitrogen atom at the 7- or 9-position of the purine nucleus,
or a salt thereof, which comprises reacting a compound represented by the formula (11-2):
wherein
X 2 and Z 2 are as defined above, and
L 2 is a halogen atom, provided that when X 2 is a halogen atom, L 2 is a halogen atom having higher leaving ability than the halogen atom represented by X 2 , or the same halogen atom as X 2 , or a salt thereof, with a compound represented by the formula (III): Me 2 (OH)C—C≡CH, in the presence of a metal catalyst and a base (1).
13 . A production method of a compound represented by the formula (1-2″):
wherein
X 2 is an alkyl group, an alkoxy group, an aryl group, an optionally protected amino group, a halogen atom or a hydrogen atom, and
Z 2 is an alkyl group, a sugar group, an amino-protecting group or a hydrogen atom, which is attached to a nitrogen atom at the 7- or 9-position of the purine nucleus,
or a salt thereof, which comprises treating a compound represented by the formula (1-2′):
wherein
X 2 and Z 2 are as defined above,
or a salt thereof, with a base (2).
14 . A production method of a compound represented by the formula (1-2″′):
wherein
A is an aryl group optionally having substituents or a heterocyclic group optionally having substituents,
X 2 is an alkyl group, an alkoxy group, an aryl group, an optionally protected amino group, a halogen atom or a hydrogen atom, and
Z 2 is an alkyl sugar group, an amino-protecting group or a hydrogen atom, which is attached to a nitrogen atom at the 7- or 9-position of the purine nucleus,
or a salt thereof, which comprises reacting a compound represented by the formula (I-2″):
wherein
X 2 and Z 2 are as defined above,
or a salt thereof, with a compound represented by the formula (IV): A-X, wherein A is as defined above, and X is a halogen atom, in the presence of a metal catalyst and a base (1).
15 . A production method of a compound represented by the formula (I-2′″):
wherein
A is an aryl group optionally having substituents or a heterocyclic group optionally having substituents,
X 2 is an alkyl group, an alkoxy group, an aryl group, an optionally protected amino group, a halogen atom or a hydrogen atom, and
Z 2 is an alkyl group, a sugar group, an amino-protecting group or a hydrogen atom, which is attached to a nitrogen atom at the 7- or 9-position of the purine nucleus,
or a salt thereof, which comprises the following steps (a)-(c):
(a) a step of obtaining a compound represented by the formula (I-2′):
wherein
X 2 is an alkyl group, an alkoxy group, an aryl group, an optionally protected amino group, a halogen atom or a hydrogen atom, and
Z 2 is an alkyl group, a sugar group, an amino-protecting group or a hydrogen atom, which is attached to a nitrogen atom at the 7- or 9-position of the purine nucleus,
or a salt thereof, which comprises reacting a compound represented by the formula (II-2):
wherein
X 2 and Z 2 are as defined above, and
L 2 is a halogen atom, provided that when X 2 is a halogen atom, L 2 is a halogen atom having higher leaving ability than the halogen atom represented by X 2 , or the same halogen atom as X 2 , or a salt thereof, with a compound represented by the formula (III): Me 2 (OH)C—C≡CH, in the presence of a metal catalyst and a base (1),
(b) a step of obtaining a compound represented by the formula (I-2″):
wherein
X 2 and Z 2 are as defined above,
or a salt thereof, which comprises treating a compound of the formula (I-2′) obtained in the step (a) or a salt thereof, with a base (2), and
(c) a step of reacting a compound of the formula (I-2″) obtained in the step (b) or a salt thereof, with a compound represented by the formula (IV): A-X, wherein A is an aryl group optionally having substituents or a heterocyclic group optionally having substituents, and X is a halogen atom, in the presence of a metal catalyst and a base (1).
16 . The production method of claim 8 , wherein the metal catalyst is a palladium compound.
17 . The production method of claim 8 , wherein the metal catalyst is a combination of a palladium compound and a copper compound.
18 . The production method of claim 17 , wherein the palladium compound is bis(triphenylphosphine)palladium dichloride or tetrakis(triphenylphosphine)palladium.
19 . The production method of claim 17 , wherein the copper compound is at least one selected from cuprous iodide, cuprous bromide and cuprous chloride.
20 . The production method of claim 8 , wherein the base (1) is trialkylamine.
21 . (canceled)
22 . The production method of claim 20 , wherein the trialkylamine is triethylamine or ethyldiisopropylamine.
23 . The production method of claim 9 , wherein the base (2) is alkali metal hydroxide or alkali metal carbonate.
24 . The production method of claim 10 , wherein the metal catalyst is a palladium compound.
25 . The production method of claim 10 , wherein the metal catalyst is a combination of a palladium compound and a copper compound.
26 . The production method of claim 25 , wherein the palladium compound is bis (triphenylphosphine) palladium dichloride or tetrakis (triphenylphosphine) palladium.
27 . The production method of claim 25 , wherein the copper compound is at least one selected from cuprous iodide, cuprous bromide and cuprous chloride.
28 . The production method of claim 10 , wherein the base (1) is trialkylamine.
29 . The production method of claim 28 , wherein the trialkylamine is triethylamine or ethyldiisopropylamine.Join the waitlist — get patent alerts
Track US2006100429A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.